Submission of Matters to a Vote of Security Holders Form 8 K

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the annual meeting of stockholders of Arcadia Biosciences, Inc. (the "Company") held on June 25, 2024 (the "Annual Meeting"), stockholders holding and entitled to vote 682,593 shares of common stock of the Company, or approximately 50.08% of the total outstanding shares of common stock on the record date for the Annual Meeting, were present in person or by proxy. At the Annual Meeting, the stockholders voted on the following four proposals, each of which is described in detail in the definitive proxy statement filed with the Securities and Exchange Commission on May 16, 2024.

The final results for each of the matters considered at the Annual Meeting were as follows:

PROPOSAL I: Election of Directors

The director nominees were elected to serve as a Class III directors until the Company's annual meeting of stockholders in 2027, or until their successors are duly elected and qualified, or their earlier resignation, death, or removal. Due to plurality election, votes could only be cast in favor of or withheld from the nominees and thus votes against were not applicable. The results of the election were as follows:

DIRECTOR NOMINEE		FOR		WITHHELD		BROKER NON-VOTES
Amy Yoder		160,017		21,356		501,220
Lilian Shackelford Murray		149,613		31,760		501,220

PROPOSAL II: Ratification of Selection of Independent Registered Public Accountants

The appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2024, was ratified by the affirmative votes of the stockholders. There were no broker non-votes on this proposal. The results of the ratification were as follows:

FOR		AGAINST		ABSTAIN
666,133		13,547		2,913

PROPOSAL III: Approval of an Amendment to the 2015 Omnibus Equity Incentive Plan

The Company's shareholders approved the amendment to our 2015 Omnibus Equity Incentive Plan by the votes set forth in the table below:

FOR		AGAINST		ABSTAIN		BROKER NON-VOTES
120,214		60,507		652		501,220

PROPOSAL IV: Advisory Vote on Executive Compensation

The Company's shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers by the votes set forth in the table below:

FOR		AGAINST		ABSTAIN		BROKER NON-VOTES
153,487		27,183		703		501,220

Public link

Please use the above public link if you want to share this noodl on another website.